{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:55:48Z","timestamp":1787061348047,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"14","license":[{"start":{"date-parts":[[2016,2,5]],"date-time":"2016-02-05T00:00:00Z","timestamp":1454630400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s00253-016-7333-y","type":"journal-article","created":{"date-parts":[[2016,2,5]],"date-time":"2016-02-05T01:15:11Z","timestamp":1454634911000},"page":"6219-6229","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Therapeutic efficacy of oral immunization with a non-genetically modified Lactococcus lactis-based vaccine CUE-GEM induces local immunity against Helicobacter pylori infection"],"prefix":"10.1007","volume":"100","author":[{"given":"Wei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhoulin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfeng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianjing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,5]]},"reference":[{"key":"7333_CR1","doi-asserted-by":"publisher","unstructured":"Bagnoli F, Fontana MR, Soldaini E, Mishra RP, Fiaschi L, Cartocci E, Nardi-Dei V, Ruggiero P, Nosari S, De Falco MG, Lofano G, Marchi S, Galletti B, Mariotti P, Bacconi M, Torre A, Maccari S, Scarselli M, Rinaudo CD, Inoshima N, Savino S, Mori E, Rossi-Paccani S, Baudner B, Pallaoro M, Swennen E, Petracca R, Brettoni C, Liberatori S, Norais N, Monaci E, Bubeck Wardenburg J, Schneewind O, O\u2019Hagan DT, Valiante NM, Bensi G, Bertholet S, De Gregorio E, Rappuoli R, Grandi G (2015) Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus. Proc Natl Acad Sci USA 112(12):3680\u20133685 doi: 10.1073\/pnas.1424924112","DOI":"10.1073\/pnas.1424924112"},{"issue":"1","key":"7333_CR2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1006\/cimm.1998.1421","volume":"191","author":"TG Blanchard","year":"1999","unstructured":"Blanchard TG, Czinn SJ, Redline RW, Sigmund N, Harriman G, Nedrud JG (1999) Antibody-independent protective mucosal immunity to gastric helicobacter infection in mice. Cell Immunol 191(1):74\u201380. doi: 10.1006\/cimm.1998.1421","journal-title":"Cell Immunol"},{"issue":"1","key":"7333_CR3","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1128\/AEM.72.1.880-889.2006","volume":"72","author":"T Bosma","year":"2006","unstructured":"Bosma T, Kanninga R, Neef J, Audouy SA, van Roosmalen ML, Steen A, Buist G, Kok J, Kuipers OP, Robillard G, Leenhouts K (2006) Novel surface display system for proteins on non-genetically modified Gram-positive bacteria. Appl Environ Microbiol 72(1):880\u2013889. doi: 10.1128\/AEM.72.1.880-889.2006","journal-title":"Appl Environ Microbiol"},{"issue":"7","key":"7333_CR4","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1046\/j.1469-0691.2002.00435.x","volume":"8","author":"L Boyanova","year":"2002","unstructured":"Boyanova L, Mentis A, Gubina M, Rozynek E, Gosciniak G, Kalenic S, Goral V, Kupcinskas L, Kantarceken B, Aydin A, Archimandritis A, Dzierzanowska D, Vcev A, Ivanova K, Marina M, Mitov I, Petrov P, Ozden A, Popova M (2002) The status of antimicrobial resistance of Helicobacter pylori in eastern Europe. Clin Microbiol Infect 8(7):388\u2013396","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"7333_CR5","doi-asserted-by":"crossref","first-page":"962","DOI":"10.4049\/jimmunol.158.2.962","volume":"158","author":"MM D\u2019Elios","year":"1997","unstructured":"D\u2019Elios MM, Manghetti M, De Carli M, Costa F, Baldari CT, Burroni D, Telford JL, Romagnani S, Del Prete G (1997) T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J Immunol 158(2):962\u2013967","journal-title":"J Immunol"},{"issue":"3","key":"7333_CR6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1523-5378.2011.00839.x","volume":"16","author":"ES DeLyria","year":"2011","unstructured":"DeLyria ES, Nedrud JG, Ernst PB, Alam MS, Redline RW, Ding H, Czinn SJ, Xu J, Blanchard TG (2011) Vaccine-induced immunity against Helicobacter pylori in the absence of IL-17A. Helicobacter 16(3):169\u2013178. doi: 10.1111\/j.1523-5378.2011.00839.x","journal-title":"Helicobacter"},{"issue":"12","key":"7333_CR7","doi-asserted-by":"crossref","first-page":"7456","DOI":"10.4049\/jimmunol.166.12.7456","volume":"166","author":"KA Eaton","year":"2001","unstructured":"Eaton KA, Mefford M, Thevenot T (2001) The role of T cell subsets and cytokines in the pathogenesis of Helicobacter pylori gastritis in mice. J Immunol 166(12):7456\u20137461","journal-title":"J Immunol"},{"issue":"12","key":"7333_CR8","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1084\/jem.188.12.2277","volume":"188","author":"TH Ermak","year":"1998","unstructured":"Ermak TH, Giannasca PJ, Nichols R, Myers GA, Nedrud J, Weltzin R, Lee CK, Kleanthous H, Monath TP (1998) Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J Exp Med 188(12):2277\u20132288","journal-title":"J Exp Med"},{"issue":"4","key":"7333_CR9","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1128\/IAI.66.4.1349-1355.1998","volume":"66","author":"RL Ferrero","year":"1998","unstructured":"Ferrero RL, Thiberge JM, Huerre M, Labigne A (1998) Immune responses of specific-pathogen-free mice to chronic Helicobacter pylori (strain SS1) infection. Infect Immun 66(4):1349\u20131355","journal-title":"Infect Immun"},{"issue":"5","key":"7333_CR10","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0264-410X(97)00247-8","volume":"16","author":"OG Gomez-Duarte","year":"1998","unstructured":"Gomez-Duarte OG, Lucas B, Yan ZX, Panthel K, Haas R, Meyer TF (1998) Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B. Vaccine 16(5):460\u2013471","journal-title":"Vaccine"},{"issue":"5","key":"7333_CR11","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/s00253-011-3726-0","volume":"93","author":"L Guo","year":"2012","unstructured":"Guo L, Li X, Tang F, He Y, Xing Y, Deng X, Xi T (2012a) Immunological features and the ability of inhibitory effects on enzymatic activity of an epitope vaccine composed of cholera toxin B subunit and B cell epitope from Helicobacter pylori urease A subunit. Appl Microbiol Biotechnol 93(5):1937\u20131945. doi: 10.1007\/s00253-011-3726-0","journal-title":"Appl Microbiol Biotechnol"},{"issue":"6","key":"7333_CR12","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s00253-012-4122-0","volume":"95","author":"L Guo","year":"2012","unstructured":"Guo L, Liu K, Xu G, Li X, Tu J, Tang F, Xing Y, Xi T (2012b) Prophylactic and therapeutic efficacy of the epitope vaccine CTB-UA against Helicobacter pylori infection in a BALB\/c mice model. Appl Microbiol Biotechnol 95(6):1437\u20131444. doi: 10.1007\/s00253-012-4122-0","journal-title":"Appl Microbiol Biotechnol"},{"issue":"8","key":"7333_CR13","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1007\/s00253-013-5408-6","volume":"98","author":"L Guo","year":"2014","unstructured":"Guo L, Yin R, Liu K, Lv X, Li Y, Duan X, Chu Y, Xi T, Xing Y (2014) Immunological features and efficacy of a multi-epitope vaccine CTB-UE against H. pylori in BALB\/c mice model. Appl Microbiol Biotechnol 98(8):3495\u20133507. doi: 10.1007\/s00253-013-5408-6","journal-title":"Appl Microbiol Biotechnol"},{"issue":"6","key":"7333_CR14","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cyto.2004.05.008","volume":"30","author":"CC Hessle","year":"2005","unstructured":"Hessle CC, Andersson B, Wold AE (2005) Gram-positive and Gram-negative bacteria elicit different patterns of pro-inflammatory cytokines in human monocytes. Cytokine 30(6):311\u2013318. doi: 10.1016\/j.cyto.2004.05.008","journal-title":"Cytokine"},{"issue":"4","key":"7333_CR15","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S0016-5085(97)70155-0","volume":"112","author":"A Lee","year":"1997","unstructured":"Lee A, O\u2019Rourke J, De Ungria MC, Robertson B, Daskalopoulos G, Dixon MF (1997) A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 112(4):1386\u20131397","journal-title":"Gastroenterology"},{"issue":"1","key":"7333_CR16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/2049-632X.12173","volume":"72","author":"X Li","year":"2014","unstructured":"Li X, Xing Y, Guo L, Lv X, Song H, Xi T (2014) Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice. Pathog Dis 72(1):78\u201386. doi: 10.1111\/2049-632X.12173","journal-title":"Pathog Dis"},{"issue":"12","key":"7333_CR17","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.4161\/hv.36096","volume":"10","author":"X Lv","year":"2014","unstructured":"Lv X, Song H, Yang J, Li T, Xi T, Xing Y (2014a) A multi-epitope vaccine CTB-UE relieves Helicobacter pylori-induced gastric inflammatory reaction via up-regulating microRNA-155 to inhibit Th17 response in C57\/BL6 mice model. Hum Vaccin Immunother 10(12):3561\u20133569. doi: 10.4161\/hv.36096","journal-title":"Hum Vaccin Immunother"},{"issue":"41","key":"7333_CR18","doi-asserted-by":"publisher","first-page":"5343","DOI":"10.1016\/j.vaccine.2014.07.041","volume":"32","author":"X Lv","year":"2014","unstructured":"Lv X, Yang J, Song H, Li T, Guo L, Xing Y, Xi T (2014b) Therapeutic efficacy of the multi-epitope vaccine CTB-UE against Helicobacter pylori infection in a Mongolian gerbil model and its microRNA-155-associated immuno-protective mechanism. Vaccine 32(41):5343\u20135352. doi: 10.1016\/j.vaccine.2014.07.041","journal-title":"Vaccine"},{"issue":"6","key":"7333_CR19","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/S0016-5085(97)70004-0","volume":"113","author":"M Mohammadi","year":"1997","unstructured":"Mohammadi M, Nedrud J, Redline R, Lycke N, Czinn SJ (1997) Murine CD4 T-cell response to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load. Gastroenterology 113(6):1848\u20131857","journal-title":"Gastroenterology"},{"issue":"11","key":"7333_CR20","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1128\/IAI.60.11.4826-4831.1992","volume":"60","author":"K Nagata","year":"1992","unstructured":"Nagata K, Mizuta T, Tonokatu Y, Fukuda Y, Okamura H, Hayashi T, Shimoyama T, Tamura T (1992) Monoclonal antibodies against the native urease of Helicobacter pylori: synergistic inhibition of urease activity by monoclonal antibody combinations. Infect Immun 60(11):4826\u20134831","journal-title":"Infect Immun"},{"issue":"2","key":"7333_CR21","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.micinf.2005.07.010","volume":"8","author":"J Nystrom","year":"2006","unstructured":"Nystrom J, Raghavan S, Svennerholm AM (2006) Mucosal immune responses are related to reduction of bacterial colonization in the stomach after therapeutic Helicobacter pylori immunization in mice. Microbes Infect 8(2):442\u2013449. doi: 10.1016\/j.micinf.2005.07.010","journal-title":"Microbes Infect"},{"issue":"32","key":"7333_CR22","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.1016\/j.vaccine.2010.05.067","volume":"28","author":"Y Qiu","year":"2010","unstructured":"Qiu Y, Wang YC, Tao HX, Zhan DW, Yuan SL, Wang P, Wang LC, Han XP, Li CS, Li JK, Liu CJ (2010) Identification of B-cell epitopes in urease B subunit of Helicobacter pylori bound by neutralizing antibodies. Vaccine 28(32):5220\u20135227. doi: 10.1016\/j.vaccine.2010.05.067","journal-title":"Vaccine"},{"issue":"2","key":"7333_CR23","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/mi.2009.131","volume":"3","author":"K Ramirez","year":"2010","unstructured":"Ramirez K, Ditamo Y, Rodriguez L, Picking WL, van Roosmalen ML, Leenhouts K, Pasetti MF (2010) Neonatal mucosal immunization with a non-living, non-genetically modified Lactococcus lactis vaccine carrier induces systemic and local Th1-type immunity and protects against lethal bacterial infection. Mucosal Immunol 3(2):159\u2013171. doi: 10.1038\/mi.2009.131","journal-title":"Mucosal Immunol"},{"issue":"3","key":"7333_CR24","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.ejpb.2010.08.003","volume":"76","author":"V Saluja","year":"2010","unstructured":"Saluja V, Visser MR, van Roosmalen ML, Leenhouts K, Huckriede A, Hinrichs WL, Frijlink HW (2010) Gastro-intestinal delivery of influenza subunit vaccine formulation adjuvanted with Gram-positive enhancer matrix (GEM) particles. Eur J Pharm Biopharm 76(3):470\u2013474. doi: 10.1016\/j.ejpb.2010.08.003","journal-title":"Eur J Pharm Biopharm"},{"issue":"11","key":"7333_CR25","doi-asserted-by":"publisher","first-page":"7085","DOI":"10.4049\/jimmunol.0803293","volume":"182","author":"A Sayi","year":"2009","unstructured":"Sayi A, Kohler E, Hitzler I, Arnold I, Schwendener R, Rehrauer H, Muller A (2009) The CD4+ T cell-mediated IFN-gamma response to Helicobacter infection is essential for clearance and determines gastric cancer risk. J Immunol 182(11):7085\u20137101. doi: 10.4049\/jimmunol.0803293","journal-title":"J Immunol"},{"issue":"9","key":"7333_CR26","doi-asserted-by":"publisher","first-page":"5121","DOI":"10.4049\/jimmunol.0901115","volume":"184","author":"Y Shi","year":"2010","unstructured":"Shi Y, Liu XF, Zhuang Y, Zhang JY, Liu T, Yin Z, Wu C, Mao XH, Jia KR, Wang FJ, Guo H, Flavell RA, Zhao Z, Liu KY, Xiao B, Guo Y, Zhang WJ, Zhou WY, Guo G, Zou QM (2010) Helicobacter pylori-induced Th17 responses modulate Th1 cell responses, benefit bacterial growth, and contribute to pathology in mice. J Immunol 184(9):5121\u20135129. doi: 10.4049\/jimmunol.0901115","journal-title":"J Immunol"},{"key":"7333_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-015-6705-z","author":"H Song","year":"2015","unstructured":"Song H, Lv X, Yang J, Liu W, Yang H, Xi T, Xing Y (2015) A novel chimeric flagellum fused with the multi-epitope vaccine CTB-UE prevents Helicobacter pylori-induced gastric cancer in a BALB\/c mouse model. Appl Microbiol Biotechnol. doi: 10.1007\/s00253-015-6705-z","journal-title":"Appl Microbiol Biotechnol"},{"issue":"11","key":"7333_CR28","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1056\/NEJMoa001999","volume":"345","author":"N Uemura","year":"2001","unstructured":"Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ (2001) Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345(11):784\u2013789. doi: 10.1056\/NEJMoa001999","journal-title":"N Engl J Med"},{"issue":"2","key":"7333_CR29","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ymeth.2005.09.015","volume":"38","author":"ML Roosmalen van","year":"2006","unstructured":"van Roosmalen ML, Kanninga R, El Khattabi M, Neef J, Audouy S, Bosma T, Kuipers A, Post E, Steen A, Kok J, Buist G, Kuipers OP, Robillard G, Leenhouts K (2006) Mucosal vaccine delivery of antigens tightly bound to an adjuvant particle made from food-grade bacteria. Methods 38(2):144\u2013149. doi: 10.1016\/j.ymeth.2005.09.015","journal-title":"Methods"},{"key":"7333_CR30","doi-asserted-by":"publisher","unstructured":"Wroblewski LE, Peek RM Jr, Wilson KT (2010) Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev 23(4):713\u2013739. doi: 10.1128\/CMR.00011-10","DOI":"10.1128\/CMR.00011-10"},{"issue":"1","key":"7333_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/hel.12178","volume":"20","author":"C Xie","year":"2015","unstructured":"Xie C, Lu NH (2015) Review: clinical management of Helicobacter pylori infection in China. Helicobacter 20(1):1\u201310. doi: 10.1111\/hel.12178","journal-title":"Helicobacter"},{"key":"7333_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60310-5","author":"M Zeng","year":"2015","unstructured":"Zeng M, Mao XH, Li JX, Tong WD, Wang B, Zhang YJ, Guo G, Zhao ZJ, Li L, Wu DL, Lu DS, Tan ZM, Liang HY, Wu C, Li DH, Luo P, Zeng H, Zhang WJ, Zhang JY, Guo BT, Zhu FC, Zou QM (2015) Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. doi: 10.1016\/S0140-6736(15)60310-5","journal-title":"Lancet"},{"issue":"44","key":"7333_CR33","doi-asserted-by":"publisher","first-page":"7664","DOI":"10.1016\/j.vaccine.2007.08.034","volume":"25","author":"W Zhao","year":"2007","unstructured":"Zhao W, Wu W, Xu X (2007) Oral vaccination with liposome-encapsulated recombinant fusion peptide of urease B epitope and cholera toxin B subunit affords prophylactic and therapeutic effects against H. pylori infection in BALB\/c mice. Vaccine 25(44):7664\u20137673. doi: 10.1016\/j.vaccine.2007.08.034","journal-title":"Vaccine"},{"issue":"36","key":"7333_CR34","doi-asserted-by":"publisher","first-page":"5013","DOI":"10.1016\/j.vaccine.2009.05.009","volume":"27","author":"WY Zhou","year":"2009","unstructured":"Zhou WY, Shi Y, Wu C, Zhang WJ, Mao XH, Guo G, Li HX, Zou QM (2009) Therapeutic efficacy of a multi-epitope vaccine against Helicobacter pylori infection in BALB\/c mice model. Vaccine 27(36):5013\u20135019. doi: 10.1016\/j.vaccine.2009.05.009","journal-title":"Vaccine"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-016-7333-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00253-016-7333-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-016-7333-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T15:23:30Z","timestamp":1692199410000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00253-016-7333-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,5]]},"references-count":34,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["7333"],"URL":"https:\/\/doi.org\/10.1007\/s00253-016-7333-y","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"value":"0175-7598","type":"print"},{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,5]]}}}